For Australian Healthcare Professionals

Report adverse event

Basket

User logged in

For Australian Healthcare Professionals

Account activated – pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process within the next 5 working days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website.

Account activated - pending validation.

In the meantime, you can enjoy the public content on our website.

X »

Anoro Ellipta 20 mcg

has been added to your basket

View Basket

Popup

Unit for Hours:H

Unit for Minutes: M

Filter redirection page URL: events-3-3.html

Filter Tags:Medical indications|Products|Therapy Area

Filter Tags values when filtered by all Tags:All Medical indications|All Products|All Therapy Area

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successfull

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successfull

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Tag Requirements value: all

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:$ciamTextareaNoCopyEmail

You are now leaving GSK’s website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the company or via the Product Information.

NP-AU-NA-WCNT-250004 Date of Approval July 2025.

Continue

Go back

Therapy areas

Primary areas of focus

Oncology

GSK is driven by our deep understanding of oncology, and determination to help advance the standard of care for people with cancer.

Respiratory

GSK develops treatments for respiratory conditions, supporting long-term disease management and symptom control in chronic respiratory illness.

Vaccines

GSK develops vaccines to help prevent infectious diseases, supporting immunisation programmes and public health.

Explore GSK products

Explore GSK products and access Product Information (PI) and Consumer Medicine Information (CMI)

Find out more

Are you looking for something else?

Request a representative

Connect with a GSK representative within your area.

Fill in the enquiry form to be contacted by a suitable GSK contact.

Resources

Support your patients and practice with a range of resources.

NP-AU-NA-WCNT-240006 Date of approval: June 2026

This site is an information service for Australian healthcare professionals only (registration and verification required). If you are a patient seeking medical advice, please consult your healthcare professional.

About this site

Trade marks are owned by or licensed to the GSK group of companies. ©2026 GSK group of companies or its licensor. For information on GSK products or to report an adverse event involving a GSK product, please contact GSK Medical Information on 1800 033 109. GlaxoSmithKline Australia Pty Ltd ABN 47 100 162 481, Melbourne, VIC. NP-AU-NA-WCNT-240009 Date of Approval: February 2026